Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction

Biochemical and Biophysical Research Communications

Volumn 491, Issue 4, 2017, Pages 1026-1033

  Li, Xin ^a,b   Dai, Yingnan ^b   Yan, Shujun ^b   Shi, Yanli ^b   Han, Baihe ^b   Li, Jingxiu ^b   Cha, Li ^b   Mu, Jianjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; AdipoR1; Ischemia and reperfusion injury; Long non coding RNA KCNQ1OT1; p38 MAPK NF B signal pathway

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CELL PROTEIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LONG NON CODING RNA KCNQ1OT1; LONG UNTRANSLATED RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYGEN; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; KCNQ1OT1 PROTEIN, HUMAN; PYRIDINE DERIVATIVE; VOLTAGE GATED POTASSIUM CHANNEL;

ACUTE HEART INFARCTION; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CARDITIS; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSFECTION; H9C2 CELL; HEART PROTECTION; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; ACUTE DISEASE; CELL CULTURE; COMPLICATION; GENETICS; HEART INFARCTION; HUMAN; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY;

ACUTE DISEASE; APOPTOSIS; CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMIDAZOLES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS, VOLTAGE-GATED; PYRIDINES; RNA, LONG NONCODING;

EID: 85028040742     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.08.005     Document Type: Article

References (33)

1. Chen, G., Shen, Y., Xu, T., Ban, F., Yin, L., et al. Rapid detection of acute myocardial infarction-related miRNA based on a Capture-interCalation-electroCatalysis (3C) strategy. Biosens. Bioelectron. 77 (2015), 1020–1025.
2. Mohammadianhafshejani, A., Secular trend changes in mean age of morbidity and mortality from an acute myocardial infarction during a 10-year period of time in Isfahan and Najaf Abad. J. Shahrekord Univ. Med. Sci. 14:6 (2013), 101–114.
3. Cenk, E., Gökhan, K., Emel, F., İmge, K., Erdem, S., et al. Early biventricular molecular responses to an acute myocardial infarction. Int. J. Med. Sci., 9, 2012, 74.
4. Rehr, R., Multiple complex coronary plaques in patients with acute myocardial infarction. NEJM, N. Engl. J. Med. 343:13 (2014), 915–922.
5. Eltzschig, H.K., Tobias, E., Ischemia and reperfusion—from mechanism to translation. Nat. Med. 17 (2011), 1391–1401.
6. Abbate, A., Kontos, M.C., Grizzard, J.D., Biondi-Zoccai, G.G., Van Tassell, B.W., et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am. J. Cardiol. 105 (2010), 1371–1377.
7. Kempf, K., Haltern, G., Füth, R., Herder, C., Müllerscholze, S., et al. Increased TNF-alpha and Decreased TGF-beta Expression in Peripheral Blood Leukocytes after Acute Myocardial Infarction, vol. 38, 2006, 346–351.
8. Di, N.P., Taccardi, A.A., De, C.R., Barsotti, A., Pathophysiology of ischemia-reperfusion injury: experimental data. Italian Heart J. Official J. Italian Fed. Cardiol. 3:Suppl 4 (2002), 349–358.
9. Hausenloy, D.J., Yellon, D.M., Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Investigation 123 (2013), 92–100.
10. Ruiz-Meana, M., García-Dorado, D., Pathophysiology of ischemia-reperfusion injury: new therapeutic options for acute myocardial infarction. Rev. Espaola De. Cardiol. 62 (2009), 199–209.
11. Yan, B., Wang, Z., Long noncoding RNA: its physiological and pathological roles. Dna Cell Biol. 31:Suppl 1 (2012), S34–S41.
12. Zhi-Juan, W.U., Zhong, J.C., Regulation role of LncRNAs and its association with diseases. Chin. J. Biochem. Mol. Biol. 28 (2012), 203–210.
13. Uchida, S., Dimmeler, S., Long noncoding RNAs in cardiovascular diseases. Circulation Res., 116, 2015, 737.
14. Wang, K., Liu, C.Y., Zhou, L.Y., Wang, J.X., Wang, M., et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun., 6, 2015, 6779.
15. Zhang, Y., Sun, L., Xuan, L., Pan, Z., Li, K., et al. Reciprocal changes of circulating long non-coding RNAsZFAS1andCDR1ASPredict acute myocardial infarction. Sci. Rep., 6, 2016, 22384.
16. Pandey, R.R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell. 32 (2008), 232–246.
17. Redrup, L., Branco, M.R., Perdeaux, E.R., Krueger, C., Lewis, A., et al. The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing. Development 136 (2009), 525–530.
18. Vausort, M., Wagner, D.R., Devaux, Y., Long noncoding RNAs in patients with acute myocardial infarction. Circulation Res. 115 (2014), 668–677.
19. Hamed, E.O., Zaky, N.A., Din, A.K.N., Serum levels of adiponectin and ghrelin in patients with acute myocardial infarction. Life Sci. J. Acta Zhengzhou Univ. Overseas Ed., 2012, 523–526.
20. Harley, K.N., Mohod, K., Jankar, J., Kumar, S., Professor, A., et al. Assessment of Serum Adiponectin and Lipid Parameters in Patients of Acute Myocardial Infarction, vol. 2845, 2015.
21. Wang, Z., Jin, Z.X., Yi, W., Yi, D.H., Effects of APPL1 knock-down on the cardioprotective actions of adiponectin against myocardial ischemia/reperfusion injury in mouse. Chin. J. Extracorpor. Circulation, 2, 2014.
22. Cao, T., Gao, Z., Gu, L., Chen, M., Yang, B., et al. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. Plos One, 9, 2014, e103793.
23. Ouchi, N., Shibata, R., Walsh, K., Cardioprotection by adiponectin. Trends Cardiovasc. Med. 16 (2006), 141–146.
24. Wang, Y., Lau, W.B., Gao, E., Tao, L., Yuan, Y., et al. Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. Am. J. Physiology Endocrinol. Metabolism, 298, 2010, E663.
25. Guo, F., Jiang, T., Song, W., Wei, H., Wang, F., et al. Electroacupuncture attenuates cerebral ischemia-reperfusion injury in diabetic mice through adiponectin receptor 1-mediated phosphorylation of GSK-3β. Mol. Neurobiol., 51, 2015, 685.
26. Niermann, C., Gorressen, S., Klier, M., Gowert, N.S., Billuart, P., et al. Oligophrenin1 protects mice against myocardial ischemia and reperfusion injury by modulating inflammation and myocardial apoptosis. Cell. Signal. 28 (2016), 967–978.
27. Huang, R., Zhou, Q., Veeraragoo, P., Yu, H., Xiao, Z., Notch2/Hes-1 pathway plays an important role in renal ischemia and reperfusion injury-associated inflammation and apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective effect. Ren. Fail. 33 (2011), 207–216.
28. Taves, S., Berta, T., Liu, D.-L., Gan, S., Chen, G., et al. Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: sex-dependent microglial signaling in the spinal cord. Brain, Behav. Immun. 55 (2015), 70–81.
29. Chai, W., Wu, Y., Li, G., Liu, Z., p38 mitogen-activated protein kinase (MAPK) abrogates insulin-mediated myocardial protection against ischemia-reperfusion (I/R) injury. Diabetes, 56, 2007, A331.
30. Guo, R.M., Xu, W.M., Lin, J.C., Mo, L.Q., Hua, X.X., et al. Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Mol. Med. Rep. 8 (2013), 603–608.
31. Guo, R., Wu, K., Chen, J., Mo, L., Hua, X., et al. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells. Cell. Physiology Biochem. Int. J. Exp. Cell. Physiology Biochem. Pharmacol. 32 (2013), 1668–1680.
32. Yuan, X., Niu, H., Wang, P., Lu, J., Zhao, H., et al. Cardioprotective effect of licochalcone D against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts. Plos One, 10, 2015, e0128375.
33. Ding, H.T., Liu, L., Wang, Z.C., Protective effect of p38 MAPK inhibitors on myocardial ischemia-reperfusion injury and apoptosis signaling pathway. J. Clin. Exp. Med. 94:6 (2014), 1843–1852.